Protein kinase A suppresses the differentiation of 3T3-L1 preadipocytes

Cell Research

Volumn 18, Issue 2, 2008, Pages 311-323

  Li, Fuqiang ^a   Wang, Dongmei ^a   Zhou, Yiran ^a   Zhou, Bo ^a   Yang, Yanan ^a   Chen, Hehua ^a   Song, Jianguo ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Adipocyte; Adipogenesis; C EBP; cAMP; PKA; PPAR

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; ARTICLE; CELL STRAIN 3T3; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; FIBROBLAST; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY;

3T3-L1 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; MICE; PHOSPHORYLATION;

EID: 38849206392     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2008.12     Document Type: Article

References (47)

1. Bennett CN, Ross SE, Longo KA, et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002; 277:30998-31004.
2. Kopelman PG. Obesity as a medical problem. Nature 2000; 404:635-643.
3. Green H, Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974; 3:127-133.
4. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995; 64:345-373.
5. Lowell BB. PPARγ: an essential regulator of adipogenesis and modulator of fat cell function. Cell 1999; 99:239-242.
6. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 2000; 16:145-171.
7. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998; 396:474-477.
8. DiPilato LM, Cheng X, Zhang J. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci USA 2004; 101:16513-16518.
9. 2+ current. Nature 1982; 298:576-588.
10. Costa MR, Casnellie JE, Catterall WA. Selective phosphorylation of the alpha subunit of the sodium channel by cAMP-dependent protein kinase. J Biol Chem 1982; 257:7918-7921.
11. Shabb JB. Physiological substrates of cAMP-dependent protein kinase. Chem Rev 2001; 101:2381-2411.
12. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 1988; 263:9402-9408.
13. Sun XJ, Rothenberg P, Kahn CR, et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352:73-77.
14. Miki H, Yamauchi T, Suzuki R, et al. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol Cell Biol 2001; 21:2521-2532.
15. Horike N, Takemori H, Katoh Y, et al. Adipose-specific expression, phosphorylation of ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J Biol Chem 2003; 278:18440-18447.
16. Katoh Y, Takemori H, Horike N, et al. Salt-inducible kinase (SIK) isoforms: their involvement in steroidogenesis and adipogenesis. Mol Cell Endocrinol 2004; 217:109-112.
17. Liu YF, Herschkovitz A, Boura-Halfon S, et al. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol Cell Biol 2004; 24:9668-9681.
18. Ara-jo EP, De Souza CT, Gasparetti AL, et al. Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistance, hyperinsulinemia, and increased adiposity. Endocrinology 2005; 146:1428-1437.
19. Evert M, Sun J, Pichler S, Slavova N, Schneider-Stock R, Dombrowski F. Insulin receptor, insulin receptor substrate-1, Raf-1, and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats. Cancer Res 2005; 64:8093-8100.
20. Temple KA, Basko X, Allison MB, Brady MJ. Uncoupling of 3T3-L1 gene expression from lipid accumulation during adipogenesis. FEBS Lett 2007; 581:469-474.
21. Roncari DA, Van RL. Promotion of human adipocyte precursor replication by 17beta-estradiol in culture. J Clin Invest 1978; 62:503-508.
22. Shao D, Lazar MA. Peroxisome proliferator activated receptor γ, CCAAT/enhancer-binding protein a, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem 1997; 272:21473-21478.
23. Zhang J, Fu M, Cui T, et al. Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity. Proc Natl Acad Sci USA 2004; 101:10703-10708.
24. Zhang JW, Tang QQ, Vinson C, Lane MD. Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 2004; 101:43-47.
25. Kim SW, Her SJ, Kim SY, Shin CS. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem Biophys Res Commun 2005; 327:811-819.
26. Brown JD, Stone DB. The mechanism of action antilipolytic agents: a comparison of the effects of PGE1, insulin, tolbutamide, and phenformin on lipolysis induced by dibutryl cyclic AMP. Diabetes 1968; 17:304-305.
27. Spiegelman BM, Green H. Cyclic AMP-mediated control of lipogenic enzyme synthesis during adipose differentiation of 3T3 cells. Cell 1981; 24:503-510.
28. Planas JV, Cummings DE, Idzerda RL, McKnight GS. Mutation of the RIIβ subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue. J Biol Chem 1999; 274:36281-36287.
29. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. Tumor necrosis factor-α stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 2002; 51:2929-2935.
30. Zhang HH, Souza SC, Muliro KV, Kraemer FB, Obin MS, Greenberg AS. Lipase-selective functional domains of perilipin A differentially regulate constitutive and protein kinase A-stimulated lipolysis. J Biol Chem 2003; 278:51535-51542.
31. Yin W, Mu J, Birnbaum MJ. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. J Biol Chem 2003; 278:43074-43080.
32. Williams IH, Polakis SE. Differentiation of 3T3-L1 fibroblasts to adipocytes. The effect of indomethacin, prostaglandin E1 and cyclic AMP on the process of differentiation. Biochem Biophys Res Commun 1977; 77:175-186.
33. Student AK, Hsu RY, Lane MD. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 1980; 255:4745-4750.
34. Hopkins NK, Gorman RR. Regulation of 3T3-L1 fibroblast differentiation by prostacyclin (prostaglandin 12). Biochim Biophys Acta 1981;663:457-466.
35. Boone C, Grégoire F, Remade C. Various stimulators of the cyclic AMP pathway fail to promote adipose conversion of porcine preadipocytes in primary culture. Differentiation 1999; 64:255-262.
36. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-d12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995; 83:803-812.
37. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995; 83:813-819.
38. Maurice DH, Palmer D, Tilley DG, et al. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol 2003; 64:533-546.
39. Kitamura T, Kitamura Y, Kuroda S, et al. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 1999; 19:6286-6296.
40. Mei J, Holst LS, Landström TR, et al. C(2)-ceramide influences the expression and insulin-mediated regulation of cyclic nucleotide phosphodiesterase 3B and lipolysis in 3T3-L1 adipocytes. Diabetes 2002; 51:631-637.
41. Torti FM, Torti SV, Larrick JW, Ringold GM. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor β. J Cell Biol 1989; 108:1105-1113.
42. Adachi H, Kurachi H, Homma H, et al. Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro. Endocrinology 1994; 135:1824-1830.
43. Serrero G, Mills D. Physiological role of epidermal growth factor on adipose tissue development in vivo. Proc Natl Acad Sci USA 1991; 88: 3912-3916.
44. Adachi H, Kurachi H, Homma H, et al. Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro. Endocrinology 1994;135:1824-1830.
45. Smas CM, Sul HS. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993; 73:725-734.
46. Zhang H, Noohr J, Jensen CH, et al. Insulin-like growth factor-1/insulin bypasses Pref-1/FA1-mediated inhibition of adipocyte differentiation. J Biol Chem 2003; 278:20906-20914.
47. Petersen RK, Jorgensen C, Rustan AC, et al. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J Lipid Res 2003; 44:2320-2330.